EndoAUAS.cVa, Scer\GAL4elav.Switch.PO is an enhancer of short lived | RU486 conditional phenotype of Hsap\APP2xAPP.SP.UAS, Scer\GAL4elav.Switch.PO
EndoAUAS.cVa, Scer\GAL4elav.Switch.PO is an enhancer of abnormal locomotor behavior | RU486 conditional phenotype of Hsap\APP2xAPP.SP.UAS, Scer\GAL4elav.Switch.PO
EndoAUAS.cVa, Scer\GAL4GMR.PF is an enhancer of visible phenotype of Ppt1UAS.cKa, Scer\GAL4GMR.PF
EndoAUAS.cVa/Scer\GAL4ey.PH is an enhancer of abnormal neuroanatomy phenotype of Synj1
EndoAUAS.cVa/Scer\GAL4ey.PH is an enhancer of abnormal neuroanatomy phenotype of Synj2
Scer\GAL4Toll-6-D42/EndoAUAS.cVa is a suppressor of abnormal neurophysiology | dominant | third instar larval stage phenotype of Vps35MH20
EndoAUAS.cVa/Scer\GAL4ey.PH is a suppressor of abnormal neurophysiology phenotype of Synj1
EndoAUAS.cVa/Scer\GAL4ey.PH is a suppressor of abnormal neurophysiology phenotype of Synj2
EndoAUAS.cVa, Scer\GAL4GMR.PF is an enhancer of eye phenotype of Ppt1UAS.cKa, Scer\GAL4GMR.PF
EndoAUAS.cVa/Scer\GAL4ey.PH is an enhancer of synaptic vesicle phenotype of Synj1
EndoAUAS.cVa/Scer\GAL4ey.PH is an enhancer of synaptic vesicle phenotype of Synj2
The expression of EndoAScer\UAS.cVa under the control of Scer\GAL4Toll-6-D42 fully suppresses the decreased excitatory junction potential amplitude under high stimulation conditions observed at the third instar larval neuromuscular junction of Vps35MH20 heterozygotes.